Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Postępy Higieny i Medycyny Doświadczalnej
Volume 76 (2022): Issue 1 (January 2022)
Open Access
Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Łukasz Bułdak
,
Estera Skudrzyk
Estera Skudrzyk
,
Grzegorz Machnik
Grzegorz Machnik
,
Aleksandra Bołdys
Aleksandra Bołdys
,
Rafał Jakub Bułdak
Rafał Jakub Bułdak
and
Bogusław Okopień
Bogusław Okopień
| Feb 20, 2022
Postępy Higieny i Medycyny Doświadczalnej
Volume 76 (2022): Issue 1 (January 2022)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original Article
Published Online:
Feb 20, 2022
Page range:
16 - 23
Received:
Jan 01, 2021
Accepted:
Jul 16, 2021
DOI:
https://doi.org/10.2478/ahem-2021-0037
Keywords
Exenatide
,
GLP-1
,
pancreatic beta cell
,
oxidative stress
,
insulin
,
PCSK9
,
LDL receptor
© 2022 Łukasz Bułdak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.